
European Journal of Medicinal Chemistry p. 619 - 622 (1989)
Update date:2022-08-03
Topics:
Chapleo, Christopher B.
Doxey, John C.
Myers, Peter L.
Myers, Malcolm
Smith, Colin F. C.
Stillings, Michael R.
A preliminary communication reported on the pharmacology of the potent partial α2-agonist (2-(1,4-benzodioxan-6-ylamino)-2-imidazoline, a 1,4-dioxan derivative of clonidine.Its degree of agonism/antagonism depended upon the peripheral or central α2-adrenoreceptor system studied.It was of interest to discover whether a similar substitution of the 1,4-dioxan moiety in other standard α-adrenergic agents would similary produce high affinity compounds of complex pharmacological profile.The same substitution when introduced into guanfacine, fenmetazole and tolazoline resulted in unpredictable changes in profile with a reduction in α-affinity. - α2-adrenoreceptors/antagonism/agonism/clonidine derivatives/1,4-dioxan derivatives
View MoreShantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
SICHUAN TONGSHENG AMINOACID CO.LTD
website:http://www.aminoacid.cc
Contact:86-838-2274206/2850606
Address:Room 1-11-1,No.19 of North TianShan Road,Deyang,Sichuan China
website:http://www.fwdchem.com
Contact:86-21-54450828
Address:Room 802,Lotus Tower ,159 Tianzhou Road,Xuhui District,Shanghai
ZHEJIANG JIANYE CHEMICAL CO.,LTD.
Contact:86-571-64149273,64149234
Address:No. 48, Fuxi Road, Meicheng Town
Contact:+86-519-86339586,13584329896
Address:Changzhou Scientific and Education Park
Doi:10.1021/jo00981a018
(1972)Doi:10.1039/c29710001496
(1971)Doi:10.1248/cpb.49.525
(2001)Doi:10.1007/BF00477394
()Doi:10.1021/acs.joc.5b01618
(2015)Doi:10.1016/S0960-894X(01)00776-4
(2002)